104 related articles for article (PubMed ID: 30538307)
1. Histone deacetylase inhibitors reactivate silenced transgene in vivo.
Zhang C; Zhang G; Liu D
Gene Ther; 2019 Apr; 26(3-4):75-85. PubMed ID: 30538307
[TBL] [Abstract][Full Text] [Related]
2. Identification of Arabidopsis histone deacetylase HDA6 mutants that affect transgene expression.
Murfett J; Wang XJ; Hagen G; Guilfoyle TJ
Plant Cell; 2001 May; 13(5):1047-61. PubMed ID: 11340181
[TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines.
Elmer JJ; Christensen MD; Barua S; Lehrman J; Haynes KA; Rege K
Biotechnol Bioeng; 2016 Jun; 113(6):1345-1356. PubMed ID: 26614912
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice.
Mehta AK; Majumdar SS; Alam P; Gulati N; Brahmachari V
Gene; 2009 Jan; 428(1-2):20-4. PubMed ID: 18976699
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells.
Garcia-Perez JL; Morell M; Scheys JO; Kulpa DA; Morell S; Carter CC; Hammer GD; Collins KL; O'Shea KS; Menendez P; Moran JV
Nature; 2010 Aug; 466(7307):769-73. PubMed ID: 20686575
[TBL] [Abstract][Full Text] [Related]
6. Silencing of Fem1cR3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity.
Pelzel HR; Schlamp CL; Waclawski M; Shaw MK; Nickells RW
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1428-35. PubMed ID: 22297488
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation and histone modifications affect the expression of the exogenous DsRed gene in transgenic goats.
Nuo MT; Yuan JL; Yang WL; Gao XY; He N; Liang H; Cang M; Liu DJ
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706651
[TBL] [Abstract][Full Text] [Related]
8. High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms.
Katz RA; Jack-Scott E; Narezkina A; Palagin I; Boimel P; Kulkosky J; Nicolas E; Greger JG; Skalka AM
J Virol; 2007 Mar; 81(6):2592-604. PubMed ID: 17202206
[TBL] [Abstract][Full Text] [Related]
9. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
[TBL] [Abstract][Full Text] [Related]
11. Influence of epigenetic modifications of the interleukin-10 promoter on IL10 gene expression.
Larsson L; Thorbert-Mros S; Rymo L; Berglundh T
Eur J Oral Sci; 2012 Feb; 120(1):14-20. PubMed ID: 22288916
[TBL] [Abstract][Full Text] [Related]
12. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
13. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling.
Savickiene J; Treigyte G; Jazdauskaite A; Borutinskaite VV; Navakauskiene R
Cell Biol Int; 2012 Nov; 36(11):1067-78. PubMed ID: 22845560
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
Lee Y; Su M; Messing A; Brenner M
Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522
[TBL] [Abstract][Full Text] [Related]
16. Position effect variegation and epigenetic modification of a transgene in a pig model.
Yin Z; Kong QR; Zhao ZP; Wu ML; Mu YS; Hu K; Liu ZH
Genet Mol Res; 2012 Feb; 11(1):355-69. PubMed ID: 22370938
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone deacetylases.
Huang Y; Shaw PG; Davidson NE
Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
[TBL] [Abstract][Full Text] [Related]
18. SIR2 is required for polycomb silencing and is associated with an E(Z) histone methyltransferase complex.
Furuyama T; Banerjee R; Breen TR; Harte PJ
Curr Biol; 2004 Oct; 14(20):1812-21. PubMed ID: 15498488
[TBL] [Abstract][Full Text] [Related]
19. Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines.
Fialova B; Smesny Trtkova K; Paskova L; Langova K; Kolar Z
Oncol Rep; 2013 May; 29(5):2039-45. PubMed ID: 23503510
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
